In contrast, other plasma biomarkers of AD pathology, including tauopathy (total tau) and neurodegeneration (neurofilament light chain [NfL]), have shown more consistent findings, with elevations seen among individuals with DS who have been diagnosed with AD (DS-AD) [13,15,21,22,23]. This evidence concerns the gene NEFL and tauopathy.